Transporters, MFS/sugar transport
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005737 | cytoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 2 |
GO:0016020 | membrane | 2 | 1 |
Related structures:
AlphaFold database: E9AG25
Term | Name | Level | Count |
---|---|---|---|
GO:0006139 | nucleobase-containing compound metabolic process | 3 | 12 |
GO:0006396 | RNA processing | 6 | 12 |
GO:0006399 | tRNA metabolic process | 7 | 12 |
GO:0006400 | tRNA modification | 6 | 12 |
GO:0006725 | cellular aromatic compound metabolic process | 3 | 12 |
GO:0006807 | nitrogen compound metabolic process | 2 | 12 |
GO:0008033 | tRNA processing | 8 | 12 |
GO:0008152 | metabolic process | 1 | 12 |
GO:0009451 | RNA modification | 5 | 12 |
GO:0009987 | cellular process | 1 | 12 |
GO:0016070 | RNA metabolic process | 5 | 12 |
GO:0034470 | ncRNA processing | 7 | 12 |
GO:0034641 | cellular nitrogen compound metabolic process | 3 | 12 |
GO:0034660 | ncRNA metabolic process | 6 | 12 |
GO:0043170 | macromolecule metabolic process | 3 | 12 |
GO:0043412 | macromolecule modification | 4 | 12 |
GO:0044237 | cellular metabolic process | 2 | 12 |
GO:0044238 | primary metabolic process | 2 | 12 |
GO:0046483 | heterocycle metabolic process | 3 | 12 |
GO:0071704 | organic substance metabolic process | 2 | 12 |
GO:0090304 | nucleic acid metabolic process | 4 | 12 |
GO:1901360 | organic cyclic compound metabolic process | 3 | 12 |
GO:0001510 | RNA methylation | 4 | 1 |
GO:0030488 | tRNA methylation | 5 | 1 |
GO:0032259 | methylation | 2 | 3 |
GO:0043414 | macromolecule methylation | 3 | 1 |
GO:0044260 | obsolete cellular macromolecule metabolic process | 3 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 12 |
GO:0016740 | transferase activity | 2 | 12 |
GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups | 3 | 12 |
GO:0102522 | tRNA 4-demethylwyosine alpha-amino-alpha-carboxypropyltransferase activity | 4 | 12 |
GO:0140098 | catalytic activity, acting on RNA | 3 | 12 |
GO:0140101 | catalytic activity, acting on a tRNA | 4 | 12 |
GO:0140640 | catalytic activity, acting on a nucleic acid | 2 | 12 |
GO:0008168 | methyltransferase activity | 4 | 3 |
GO:0008173 | RNA methyltransferase activity | 4 | 1 |
GO:0008175 | tRNA methyltransferase activity | 5 | 1 |
GO:0016741 | transferase activity, transferring one-carbon groups | 3 | 3 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 134 | 136 | PF00675 | 0.381 |
CLV_NRD_NRD_1 | 156 | 158 | PF00675 | 0.425 |
CLV_NRD_NRD_1 | 161 | 163 | PF00675 | 0.389 |
CLV_NRD_NRD_1 | 166 | 168 | PF00675 | 0.318 |
CLV_NRD_NRD_1 | 38 | 40 | PF00675 | 0.503 |
CLV_NRD_NRD_1 | 44 | 46 | PF00675 | 0.485 |
CLV_NRD_NRD_1 | 76 | 78 | PF00675 | 0.347 |
CLV_NRD_NRD_1 | 80 | 82 | PF00675 | 0.342 |
CLV_PCSK_KEX2_1 | 134 | 136 | PF00082 | 0.405 |
CLV_PCSK_KEX2_1 | 156 | 158 | PF00082 | 0.415 |
CLV_PCSK_KEX2_1 | 161 | 163 | PF00082 | 0.344 |
CLV_PCSK_KEX2_1 | 168 | 170 | PF00082 | 0.243 |
CLV_PCSK_KEX2_1 | 323 | 325 | PF00082 | 0.317 |
CLV_PCSK_KEX2_1 | 37 | 39 | PF00082 | 0.555 |
CLV_PCSK_KEX2_1 | 379 | 381 | PF00082 | 0.364 |
CLV_PCSK_KEX2_1 | 76 | 78 | PF00082 | 0.329 |
CLV_PCSK_PC1ET2_1 | 168 | 170 | PF00082 | 0.438 |
CLV_PCSK_PC1ET2_1 | 323 | 325 | PF00082 | 0.362 |
CLV_PCSK_PC1ET2_1 | 37 | 39 | PF00082 | 0.557 |
CLV_PCSK_PC1ET2_1 | 379 | 381 | PF00082 | 0.364 |
CLV_PCSK_PC7_1 | 157 | 163 | PF00082 | 0.427 |
CLV_PCSK_SKI1_1 | 150 | 154 | PF00082 | 0.331 |
CLV_PCSK_SKI1_1 | 209 | 213 | PF00082 | 0.287 |
CLV_PCSK_SKI1_1 | 312 | 316 | PF00082 | 0.362 |
CLV_PCSK_SKI1_1 | 34 | 38 | PF00082 | 0.585 |
CLV_PCSK_SKI1_1 | 371 | 375 | PF00082 | 0.313 |
CLV_PCSK_SKI1_1 | 46 | 50 | PF00082 | 0.546 |
CLV_PCSK_SKI1_1 | 7 | 11 | PF00082 | 0.547 |
CLV_PCSK_SKI1_1 | 76 | 80 | PF00082 | 0.422 |
DEG_APCC_DBOX_1 | 134 | 142 | PF00400 | 0.605 |
DOC_CYCLIN_RxL_1 | 4 | 13 | PF00134 | 0.298 |
DOC_MAPK_gen_1 | 134 | 142 | PF00069 | 0.624 |
DOC_MAPK_MEF2A_6 | 134 | 142 | PF00069 | 0.624 |
DOC_MAPK_MEF2A_6 | 7 | 14 | PF00069 | 0.268 |
DOC_PIKK_1 | 95 | 103 | PF02985 | 0.549 |
DOC_PP1_RVXF_1 | 207 | 213 | PF00149 | 0.470 |
DOC_PP1_RVXF_1 | 315 | 322 | PF00149 | 0.424 |
DOC_PP4_FxxP_1 | 243 | 246 | PF00568 | 0.476 |
DOC_PP4_FxxP_1 | 26 | 29 | PF00568 | 0.646 |
DOC_USP7_MATH_1 | 179 | 183 | PF00917 | 0.637 |
DOC_USP7_MATH_1 | 327 | 331 | PF00917 | 0.525 |
DOC_USP7_MATH_1 | 68 | 72 | PF00917 | 0.613 |
DOC_USP7_UBL2_3 | 30 | 34 | PF12436 | 0.772 |
DOC_WW_Pin1_4 | 187 | 192 | PF00397 | 0.563 |
LIG_14-3-3_CanoR_1 | 156 | 160 | PF00244 | 0.600 |
LIG_14-3-3_CanoR_1 | 169 | 177 | PF00244 | 0.592 |
LIG_14-3-3_CanoR_1 | 186 | 193 | PF00244 | 0.604 |
LIG_14-3-3_CanoR_1 | 317 | 322 | PF00244 | 0.476 |
LIG_14-3-3_CanoR_1 | 366 | 373 | PF00244 | 0.534 |
LIG_14-3-3_CanoR_1 | 7 | 13 | PF00244 | 0.342 |
LIG_Actin_WH2_2 | 262 | 278 | PF00022 | 0.525 |
LIG_Actin_WH2_2 | 336 | 353 | PF00022 | 0.635 |
LIG_Actin_WH2_2 | 358 | 373 | PF00022 | 0.589 |
LIG_BRCT_BRCA1_1 | 189 | 193 | PF00533 | 0.549 |
LIG_BRCT_BRCA1_1 | 264 | 268 | PF00533 | 0.501 |
LIG_BRCT_BRCA1_2 | 264 | 270 | PF00533 | 0.501 |
LIG_Clathr_ClatBox_1 | 123 | 127 | PF01394 | 0.596 |
LIG_DLG_GKlike_1 | 134 | 141 | PF00625 | 0.625 |
LIG_EH1_1 | 381 | 389 | PF00400 | 0.535 |
LIG_FHA_1 | 14 | 20 | PF00498 | 0.326 |
LIG_FHA_1 | 192 | 198 | PF00498 | 0.484 |
LIG_FHA_1 | 242 | 248 | PF00498 | 0.470 |
LIG_FHA_1 | 3 | 9 | PF00498 | 0.451 |
LIG_FHA_1 | 58 | 64 | PF00498 | 0.566 |
LIG_FHA_2 | 225 | 231 | PF00498 | 0.581 |
LIG_FHA_2 | 96 | 102 | PF00498 | 0.597 |
LIG_LIR_Gen_1 | 265 | 275 | PF02991 | 0.517 |
LIG_LIR_Nem_3 | 112 | 117 | PF02991 | 0.555 |
LIG_LIR_Nem_3 | 235 | 240 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 265 | 271 | PF02991 | 0.476 |
LIG_NRBOX | 5 | 11 | PF00104 | 0.369 |
LIG_Pex14_2 | 110 | 114 | PF04695 | 0.516 |
LIG_Pex14_2 | 79 | 83 | PF04695 | 0.532 |
LIG_SH2_CRK | 336 | 340 | PF00017 | 0.504 |
LIG_SH2_STAP1 | 203 | 207 | PF00017 | 0.505 |
LIG_SH2_STAT5 | 21 | 24 | PF00017 | 0.376 |
LIG_SH2_STAT5 | 242 | 245 | PF00017 | 0.476 |
LIG_SH2_STAT5 | 307 | 310 | PF00017 | 0.471 |
LIG_SUMO_SIM_par_1 | 120 | 125 | PF11976 | 0.490 |
LIG_SUMO_SIM_par_1 | 8 | 13 | PF11976 | 0.446 |
LIG_TRAF2_1 | 345 | 348 | PF00917 | 0.583 |
LIG_TRAF2_1 | 99 | 102 | PF00917 | 0.582 |
LIG_TYR_ITIM | 18 | 23 | PF00017 | 0.339 |
LIG_TYR_ITIM | 240 | 245 | PF00017 | 0.328 |
LIG_TYR_ITIM | 334 | 339 | PF00017 | 0.369 |
LIG_UBA3_1 | 304 | 312 | PF00899 | 0.444 |
LIG_WRC_WIRS_1 | 202 | 207 | PF05994 | 0.449 |
MOD_CK1_1 | 13 | 19 | PF00069 | 0.475 |
MOD_CK1_1 | 173 | 179 | PF00069 | 0.492 |
MOD_CK1_1 | 214 | 220 | PF00069 | 0.397 |
MOD_CK2_1 | 95 | 101 | PF00069 | 0.529 |
MOD_GlcNHglycan | 213 | 216 | PF01048 | 0.328 |
MOD_GlcNHglycan | 26 | 29 | PF01048 | 0.613 |
MOD_GlcNHglycan | 330 | 333 | PF01048 | 0.461 |
MOD_GlcNHglycan | 343 | 346 | PF01048 | 0.476 |
MOD_GSK3_1 | 146 | 153 | PF00069 | 0.490 |
MOD_GSK3_1 | 169 | 176 | PF00069 | 0.475 |
MOD_GSK3_1 | 185 | 192 | PF00069 | 0.373 |
MOD_GSK3_1 | 201 | 208 | PF00069 | 0.309 |
MOD_GSK3_1 | 210 | 217 | PF00069 | 0.145 |
MOD_N-GLC_1 | 215 | 220 | PF02516 | 0.328 |
MOD_N-GLC_2 | 62 | 64 | PF02516 | 0.398 |
MOD_NEK2_1 | 110 | 115 | PF00069 | 0.378 |
MOD_NEK2_1 | 155 | 160 | PF00069 | 0.483 |
MOD_NEK2_1 | 180 | 185 | PF00069 | 0.472 |
MOD_NEK2_1 | 205 | 210 | PF00069 | 0.396 |
MOD_NEK2_1 | 211 | 216 | PF00069 | 0.205 |
MOD_NEK2_1 | 8 | 13 | PF00069 | 0.449 |
MOD_NEK2_2 | 151 | 156 | PF00069 | 0.445 |
MOD_PKA_1 | 134 | 140 | PF00069 | 0.514 |
MOD_PKA_2 | 134 | 140 | PF00069 | 0.510 |
MOD_PKA_2 | 155 | 161 | PF00069 | 0.492 |
MOD_PKA_2 | 185 | 191 | PF00069 | 0.543 |
MOD_PKA_2 | 328 | 334 | PF00069 | 0.463 |
MOD_PKA_2 | 365 | 371 | PF00069 | 0.521 |
MOD_PKB_1 | 167 | 175 | PF00069 | 0.515 |
MOD_Plk_1 | 180 | 186 | PF00069 | 0.552 |
MOD_Plk_1 | 205 | 211 | PF00069 | 0.432 |
MOD_Plk_1 | 68 | 74 | PF00069 | 0.521 |
MOD_Plk_2-3 | 96 | 102 | PF00069 | 0.530 |
MOD_Plk_4 | 13 | 19 | PF00069 | 0.372 |
MOD_Plk_4 | 310 | 316 | PF00069 | 0.371 |
MOD_Plk_4 | 317 | 323 | PF00069 | 0.308 |
MOD_ProDKin_1 | 187 | 193 | PF00069 | 0.445 |
MOD_SUMO_rev_2 | 41 | 48 | PF00179 | 0.661 |
TRG_DiLeu_BaEn_3 | 359 | 365 | PF01217 | 0.474 |
TRG_DiLeu_BaEn_4 | 101 | 107 | PF01217 | 0.418 |
TRG_DiLeu_BaLyEn_6 | 4 | 9 | PF01217 | 0.502 |
TRG_ENDOCYTIC_2 | 20 | 23 | PF00928 | 0.339 |
TRG_ENDOCYTIC_2 | 242 | 245 | PF00928 | 0.328 |
TRG_ENDOCYTIC_2 | 336 | 339 | PF00928 | 0.365 |
TRG_ER_diArg_1 | 133 | 135 | PF00400 | 0.517 |
TRG_ER_diArg_1 | 155 | 157 | PF00400 | 0.531 |
TRG_ER_diArg_1 | 161 | 163 | PF00400 | 0.543 |
TRG_ER_diArg_1 | 76 | 78 | PF00400 | 0.401 |
TRG_NES_CRM1_1 | 355 | 369 | PF08389 | 0.481 |
TRG_NLS_Bipartite_1 | 156 | 171 | PF00514 | 0.494 |
TRG_NLS_MonoExtC_3 | 33 | 38 | PF00514 | 0.735 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P4L5 | Leptomonas seymouri | 64% | 97% |
A0A0S4JHI6 | Bodo saltans | 49% | 95% |
A0A1X0P9M7 | Trypanosomatidae | 57% | 95% |
A0A422N7F4 | Trypanosoma rangeli | 53% | 100% |
A0A451EJL2 | Leishmania donovani | 100% | 100% |
A4H3H8 | Leishmania braziliensis | 83% | 100% |
D0A212 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 51% | 99% |
E9ACF3 | Leishmania major | 94% | 100% |
E9AJP1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
V5B8P6 | Trypanosoma cruzi | 51% | 100% |